Back to Fisher Asset Management, LLC Fisher Asset Management, LLC

CLDXCLDX
16 quarters

Position history for Fisher Asset Management, LLCFisher Asset Management, LLC's holdings in Celldex Therapeutics, Inc.

Fisher Asset Management, LLC holds 985,677 shares of CLDX (Celldex Therapeutics, Inc.), worth $36.7M as of 2026-Q2. The position was decreased (-2.8% shares). CLDX represents 0.0% of Fisher Asset Management, LLC's portfolio.

Current Value

$36.7M

Current Shares

985,677

Total Value Change

+$35.7M

Total Shares Change

+951,784

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
985,677
-2.8%
$36.7M0.0%$37.21
0
2026-Q1
Increased
1M
+8.2%
$32.2M0.0%$28.94
31
2025-Q4
Increased
937,158
+1.1%
$25.5M0.0%$26.43
29
2025-Q3
Increased
927,157
+12.8%
$24M0.0%$26.19
32
2025-Q2
Decreased
822,208
-5.7%
$16.7M0.0%$20.29
0
2025-Q1
Increased
871,628
+92.6%
$15.8M0.0%$19.93
45
2024-Q4
Increased
452,497
+20.9%
$11.4M0.0%$25.12
33
2024-Q3
Increased
374,352
+210.6%
$12.7M0.0%$33.20
45
2024-Q2
Decreased
120,544
-2.7%
$4.5M0.0%$37.01
0
2024-Q1
Increased
123,836
+467.7%
$5.2M0.0%$41.97
44
2023-Q4
Increased
21,812
+6.2%
$865,0630.0%$39.66
26
2023-Q3
Unchanged
20,538
0.0%
$565,2050.0%$27.52
0
2023-Q2
Unchanged
20,538
0.0%
$696,8540.0%$34.58
0
2023-Q1
Decreased
20,538
-29.2%
$738,9570.0%$35.58
0
2022-Q4
Decreased
29,017
-14.4%
$1.3M0.0%$44.57
0
2022-Q3
New
33,893
-
$953,0000.0%$28.35
35

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used